Lapatinib Completed Phase 1 Trials for Solid Tumor Cancers / Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00148902Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)
NCT00388076Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)
NCT00371488GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer
NCT00462956GW572016 In Patients With Advanced Or Metastatic Breast Cancer
NCT00790816Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
NCT00996762A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib